Ramón y Cajal Researcher at the Faculty of Pharmacy and Food Science of the University of Barcelona (UB) since 2023. She completed her PhD in Molecular Medicine at the University of Santiago de Compostela (USC), and held postdoctoral positions at the MRC London Institute of Medical Sciences (MRC LMS, Imperial College London, UK) and the UK Dementia Research Institute (UK DRI at University College London, The Francis Crick Institute, UK). Her postdoctoral research explored the potential of cellular senescence as a therapeutic target, leading to the identification of novel pharmacological modulators of senescence, including senolytic compounds (Guerrero et al. 2019, Nature Metabolism; Guerrero et al. 2020, Aging Cell) and drugs alleviating senescence (Guerrero et al. 2022, Nature Aging). Her current research programme explores the contribution of cellular senescence and ageing to neurodegeneration, with a particular focus on Alzheimer´s Disease.

ORCID es 0000-0002-4622-9201

I am a Pharmacy graduate by the University of Barcelona. As an undergraduate student, I spent time in the Neurosciences group led by Dr. M. Pallàs and Dr. C. Griñán-Ferré participating in different research projects. After graduating, I had the opportunity to do an internship in the Neurosciences Group in Maciel Group  (Universidade do Minho, Braga), where I learned to work with C. Elegans through the study of new targets for Machado Joseph disease. In October 2020, I started my PhD studying the role of the histone methyltransferase G9a/GLP  in neurodegeneration using C. elegans and mice as experimental models.

She successfully completed her PhD in Molecular Biology, Biomedicine and Clinical at the University of Seville (US). During her PhD, she investigated the subcellular localization dynamics of the transcription factor HLH-30, the Caenorhabditis elegans orthologue of TFEB/TFE3. In September 2025, she joined the Neuropharmacology of Aging and Neurodegeneration group as a postdoctoral researcher. Her current studies explore the molecular pathways involved in neurodegenerative diseases using C. elegans as a model organism.

ORCID: 0000-0002-8290-6070

She is a Pharmacy graduated from National University of Asunción (Paraguay). At 2021, She finished MSc program in Pharmaceutical Sciences (National University of Asunción, Paraguay). During the career and the MSc program, she has been involved in research projects about medicinal drugs and their effect in CNS. Recently she joined at the Dr. M. Pallàs and Dr. C. Griñán team, as an PhD student at Faculty of Pharmacy and Food Science at the Universitat de Barcelona, in the Neuropharmacology of Aging and Neurodegeneration group, to search the molecular pathways involved in the Alzheimer Disease and other neurodegenerative diseases. She is interested in new drugs to face cognitive decline in ageing and neurodegenerative diseases that exert effect at the Imidazoline receptors (I₂-IR) in mice and the molecular pathways involved in their effect.

ORCID: 0000-0002-9666-333X

In 2023, she completed her degree in Pharmacy at the Universitat de Barcelona (UB). She subsequently joined the research team led by Dr. M. Pallàs and Dr. C. Griñán-Ferré as a PhD student at the Faculty of Pharmacy and Food Sciences of the same university. She is currently a member of the Neuropharmacology of Aging and Neurodegeneration research group, where her work focuses on investigating the molecular pathways involved in Alzheimer’s disease and other neurodegenerative disorders.